What You Should Know:
– The University of Texas MD Anderson Cancer Center and HealthEx announced a strategic collaboration to develop tools aimed at streamlining the patient consent process, while simultaneously creating greater transparency and control for patients over how their data is used in research.
– As part of this collaboration, the two organizations will work on the continued development and future implementation of HealthEx’s artificial intelligence (AI)-driven global consent and data rights management platform. The goal is to enable fast, compliant, and patient-centric data access, building on the complementary strengths of both institutions to advance data-driven research while ensuring proper stewardship of patient data.
A Patient-Centric, AI-Augmented Model
HealthEx’s platform utilizes AI to help organizations create, manage, and enforce patient consents and preferences. A key feature is its data policy engine, which establishes automated workflows to ensure compliance with both patient preferences and institutional policies. The technology is designed to give patients direct control over how they contribute their data to current and future research.
“MD Anderson and HealthEx strive to pioneer a patient-centric, transparent, and AI-augmented model for health data management,” said Priyanka Agarwal, M.D., MBA, co-founder and chief executive officer at HealthEx. “Our vision is to change how data serves both patients and health care institutions. By transforming consent and data access policies, we can maximize the value of health data, strengthen patient trust, and improve health care for everyone.”
Working together, HealthEx and MD Anderson will evaluate methods to leverage this platform to streamline future consenting approaches, creating a system that benefits patients while enabling impactful cancer research.
